51 results
424B5
XENE
Xenon Pharmaceuticals Inc
30 Nov 23
Prospectus supplement for primary offering
4:18pm
shares, or issue shares upon exercise or conversion of related securities, pursuant to any stock option, stock bonus or other stock plan or arrangement
8-K
EX-1.1
XENE
Xenon Pharmaceuticals Inc
30 Nov 23
Entry into a Material Definitive Agreement
4:15pm
and the Prospectus. The descriptions of the Company’s stock option, stock bonus and other stock plans or arrangements, and the options or other rights … or options to purchase Shares, or issue Shares upon exercise or conversion of Related Securities, pursuant to any stock option, stock bonus or other stock
424B5
XENE
Xenon Pharmaceuticals Inc
29 Nov 23
Prospectus supplement for primary offering
5:05pm
to any stock option, stock bonus or other stock plan or arrangement or other related securities described herein, provided that, in the case of options
8-K
EX-1.1
2r7yvei g6h
23 Jun 22
Other Events
4:04pm
8-K
EX-1.1
3smvi5w4i
6 Oct 21
Other Events
4:50pm
8-K
EX-1.1
ogbxmpr55l4pry4
10 Mar 21
Other Events
5:24pm
8-K
afujkgc2v7d x98
14 Jan 21
Topline Data from XEN1101 Phase 2b X-TOLE Clinical Trial in Adult Focal Epilepsy on Track for Third Quarter of 2021
8:05am
8-K
EX-10.3
6q3iwcime0a0qx7qwb
14 Jan 21
Topline Data from XEN1101 Phase 2b X-TOLE Clinical Trial in Adult Focal Epilepsy on Track for Third Quarter of 2021
8:05am
8-K
EX-10.2
ewq j8cuuwgiec96v
14 Jan 21
Topline Data from XEN1101 Phase 2b X-TOLE Clinical Trial in Adult Focal Epilepsy on Track for Third Quarter of 2021
8:05am
8-K
EX-10.4
x6144swqr7qdqsn
14 Jan 21
Topline Data from XEN1101 Phase 2b X-TOLE Clinical Trial in Adult Focal Epilepsy on Track for Third Quarter of 2021
8:05am
8-K
EX-1.1
vnolv
6 Aug 20
Entry into a Material Definitive Agreement
4:56pm